234 related articles for article (PubMed ID: 7769243)
1. Phage display of disulfide-stabilized Fv fragments.
Brinkmann U; Chowdhury PS; Roscoe DM; Pastan I
J Immunol Methods; 1995 May; 182(1):41-50. PubMed ID: 7769243
[TBL] [Abstract][Full Text] [Related]
2. Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.
Huang YJ; Chen IC; Yu CM; Lee YC; Hsu HJ; Ching AT; Chang HJ; Yang AS
J Biol Chem; 2010 Mar; 285(11):7880-91. PubMed ID: 20068035
[TBL] [Abstract][Full Text] [Related]
3. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
[TBL] [Abstract][Full Text] [Related]
4. A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: comparison with its single-chain and disulfide-stabilized homologs.
Rajagopal V; Pastan I; Kreitman RJ
Protein Eng; 1997 Dec; 10(12):1453-9. PubMed ID: 9543007
[TBL] [Abstract][Full Text] [Related]
5. Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation.
Reiter Y; Brinkmann U; Jung SH; Pastan I; Lee B
Protein Eng; 1995 Dec; 8(12):1323-31. PubMed ID: 8869646
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
Reiter Y; Kreitman RJ; Brinkmann U; Pastan I
Int J Cancer; 1994 Jul; 58(1):142-9. PubMed ID: 8014011
[TBL] [Abstract][Full Text] [Related]
7. The role of valency in the selection of anti-carbohydrate single-chain Fvs from phage display libraries.
MacKenzie R; To R
J Immunol Methods; 1998 Nov; 220(1-2):39-49. PubMed ID: 9839924
[TBL] [Abstract][Full Text] [Related]
8. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.
Reiter Y; Brinkmann U; Lee B; Pastan I
Nat Biotechnol; 1996 Oct; 14(10):1239-45. PubMed ID: 9631086
[TBL] [Abstract][Full Text] [Related]
9. Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment.
Kobayashi H; Han ES; Kim IS; Le N; Rajagopal V; Kreitman RJ; Pastan I; Paik CH; Carrasquillo JA
Nucl Med Biol; 1998 May; 25(4):387-93. PubMed ID: 9639301
[TBL] [Abstract][Full Text] [Related]
10. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
Reiter Y; Pastan I
Clin Cancer Res; 1996 Feb; 2(2):245-52. PubMed ID: 9816166
[TBL] [Abstract][Full Text] [Related]
11. Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF.
Chen IC; Yu CM; Lee YC; Huang YJ; Hsu HJ; Yang AS
Mol Biosyst; 2010 Jul; 6(7):1307-15. PubMed ID: 20424732
[TBL] [Abstract][Full Text] [Related]
12. Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure.
Reiter Y; Kurucz I; Brinkmann U; Jung SH; Lee B; Segal DM; Pastan I
Immunity; 1995 Mar; 2(3):281-7. PubMed ID: 7697545
[TBL] [Abstract][Full Text] [Related]
13. Phage versus phagemid libraries for generation of human monoclonal antibodies.
O'Connell D; Becerril B; Roy-Burman A; Daws M; Marks JD
J Mol Biol; 2002 Aug; 321(1):49-56. PubMed ID: 12139932
[TBL] [Abstract][Full Text] [Related]
14. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Brinkmann U; Reiter Y; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7538-42. PubMed ID: 8356052
[TBL] [Abstract][Full Text] [Related]
15. Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.
He FT; Nie YZ; Chen BJ; Qiao TD; Fan DM; Li RF; Kang YS; Zhang Y
World J Gastroenterol; 2002 Apr; 8(2):258-62. PubMed ID: 11925603
[TBL] [Abstract][Full Text] [Related]
16. Effects of signal sequence on phage-displayed disulfide-stabilized single chain antibody variable fragment (sc-dsFv) libraries.
Lee YC; Chen IC; Yu CM; Huang YJ; Hsu HJ; Yang AS
Biochem Biophys Res Commun; 2011 Jul; 411(2):348-53. PubMed ID: 21741355
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
19. Vl-linker-Vh orientation-dependent expression of single chain Fv-containing an engineered disulfide-stabilized bond in the framework regions.
Luo D; Mah N; Krantz M; Wilde K; Wishart D; Zhang Y; Jacobs F; Martin L
J Biochem; 1995 Oct; 118(4):825-31. PubMed ID: 8576099
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
Reiter Y; Brinkmann U; Kreitman RJ; Jung SH; Lee B; Pastan I
Biochemistry; 1994 May; 33(18):5451-9. PubMed ID: 7910034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
